Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 24, Number 30, 2017

Articles

Free Content Meet Our Editorial Board Member
pp. 3217-3217(1)
Author: Witczak, Zbigniew J.

Favourites:
ADD

Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk
pp. 3218-3230(13)
Authors: Carnevali, Silvia; Buccellati, Carola; Bolego, Chiara; Bertinaria, Massimo; Rovati, G. E.; Sala, Angelo

Favourites:
ADD

Circulating ACE2 in Cardiovascular and Kidney Diseases
pp. 3231-3241(11)
Authors: Anguiano, L.; Riera, M.; Pascual, J.; Soler, M. J.

Favourites:
ADD

Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features
pp. 3242-3253(12)
Authors: Tran-Nguyen, Viet-Khoa; Prasad, Rajendra; Falson, Pierre; Boumendjel, Ahcene

Favourites:
ADD

Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents
pp. 3254-3282(29)
Authors: Almeida, J.R.; Resende, L.M.; Watanabe, R.K.; Carregari, V.C.; Huancahuire-Vega, S.; da S. Caldeira, C.A.; Coutinho-Neto, A.; Soares, A.M.; Vale, N.; de C. Gomes, P.A.; Marangoni, S.; de A. Calderon, L.; Da Silva, S.L.

Favourites:
ADD

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
pp. 3283-3309(27)
Authors: Lazarevic-Pasti, Tamara; Leskovac, Andreja; Momic, Tatjana; Petrovic, Sandra; Vasic, Vesna

Favourites:
ADD

Drug Encapsulated Nanoparticles for Treating Targeted Cells
pp. 3310-3321(12)
Authors: Suk, Koh H.; Gopinath, Subash C.B.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content